Why Cadex exists
Cadex Genomics offers liquid biopsy services, analyzing blood and other bodily fluids such as urine and saliva for biomarkers including DNA, RNA, and proteins. The testing supports treatment guidance, minimum residual disease monitoring, and early detection. It gives patients a fluid-based way to gather distinctive biomarkers that can shape care decisions.
- 1
Tumor DNA enters the blood
Tumors shed DNA into the bloodstream, where it can be measured from a blood sample.
- 2
Baseline before treatment
The concentration of tumor DNA in the blood is measured before treatment begins.
- 3
Compare after the first cycle
A second measurement after the first treatment cycle is compared with the baseline. An increased DNA concentration indicates tumor growth and a treatment that is not working.
Prefer the source? Cadex Genomics's own site has more.
